The global therapy devices market size was valued at USD 27.69 billion in 2025 and is projected to grow from USD 29.67 billion in 2026 to USD 51.51 billion by 2034, registering a CAGR of 7.14% during the forecast period (2026–2034). North America dominated the therapy devices market with a share of 45.08% in 2025.
Therapy devices are healthcare devices designed to treat, manage, or alleviate diseases, injuries, pain, and other health conditions through physical, electrical, mechanical, thermal, or other therapeutic mechanisms. These devices include electrical stimulators, diathermy systems, therapeutic ultrasound equipment, rehabilitation devices, and other technologies used to support patient treatment and recovery. Therapy devices are tracked under HSN Code 9019 (mechano-therapy appliances, massage apparatus, psychological aptitude-testing apparatus, and ozone, oxygen, aerosol, artificial respiration, or other therapeutic respiration apparatus) and SIC Code 3845 (electromedical and electrotherapeutic apparatus).
The therapy devices market demand is supported by increasing rehabilitation needs and the adoption of non-invasive therapeutic technologies and pain management devices. Healthcare providers are increasingly using electrical stimulation, therapeutic ultrasound, diathermy, and other treatment devices for pain management, physical rehabilitation, and disease treatment, contributing to the therapy devices market growth.
• 2025 Market Size: USD 27.69 Billion• 2026 Market Size: USD 29.61 Billion• 2034 Projected Market Size: USD 51.40 Billion• Forecast Period: 2026–2034• Base Year: 2025• Market CAGR (2026–2034): 7.14%
• Largest Regional Market (2025): North America• North America Market Share (2025): 45.08%• Fastest-growing Region: Asia Pacific• Asia Pacific CAGR (2026–2034): 8.73%
By Product Type
• Leading Segment: Respiratory Therapy Devices• Market Share in 2025: 12.63%
By Application
• Fastest-growing Segment: Sleep Apnea• CAGR: 8.68% (2026–2034)
By End User
• Leading Segment: Hospitals & Specialty Clinics• Market Share in 2025: 38.64%
Download a Free Sample To learn more about this report,
Adoption of Closed-Loop Therapy Systems for Patient Feedback
Closed-loop therapy systems are using sensors and patient feedback to adjust treatment settings during therapy. These systems can automatically modify stimulation or treatment intensity based on changes in patient response. This development makes therapy devices more responsive and personalized.
Development of Robotic Rehabilitation Devices for Physical Therapy
The therapy devices market analysis shows that robotic rehabilitation devices are being used to support repetitive and controlled movements during physical therapy and patient recovery. These rehabilitation devices can assist with walking, arm movement, and other exercises while maintaining consistent treatment patterns. This technology strengthens rehabilitation technology for neurological and physical recovery.
Supply chain disruptions are expected to have a moderate impact on the therapy devices market share, as dependence on electronic components, sensors, motors, batteries, medical-grade materials, and specialized device components can create procurement delays and higher manufacturing costs. The market is likely to follow a K-shaped recovery pattern, as robotic rehabilitation, connected therapy, and other technology-intensive devices can recover at different rates from simpler electrotherapy and conventional rehabilitation equipment. The market is expected to grow at a CAGR of 7.14%, but supply chain constraints could approximately lower this by 0.4 percentage points, resulting in short-term growth of around 6.74%. As supply conditions normalize through improved availability of electronics and batteries, broader supplier networks, restored manufacturing capacity, and more reliable medical-device logistics, therapy device market growth is expected to gradually return to 7.14%.
The therapy devices market forecasts investments directed toward domestic medical device manufacturing, advanced therapeutic technologies, clinical studies, and rehabilitation equipment.
Key Investment and Funding Activities in the Therapy Devices Market, 2026
Pulnovo Medical
USD 100 million
In April 2026, Pulnovo Medical raised USD 100 million in an oversubscribed strategic financing round, led by Medtronic, to advance its device-based therapies for pulmonary hypertension and heart failure and support global expansion.
Sonire Therapeutics
USD 18 million in Series A funding
In April 2026, Sonire Therapeutics raised USD 18 million in Series A funding to advance its non-invasive high-intensity focused ultrasound (HIFU) therapy for pancreatic cancer, including completion of a randomized clinical trial, U.S. regulatory development, and global commercialization.
Musculoskeletal Disease Burden and Post-Surgical Recovery Needs Drive Market
The rising prevalence of musculoskeletal disorders such as osteoarthritis, back disorders, and joint conditions is increasing the need for non-invasive rehabilitation and pain management. Therapy devices can support mobility, muscle function, and pain relief during treatment. A larger population with movement-related conditions therefore increases demand for these devices.
Higher volumes of orthopedic and other surgical procedures are increasing the need for structured patient recovery after treatment. Physical therapy equipment can support mobility training, muscle strengthening, and functional recovery during postoperative rehabilitation. Greater focus on restoring physical function is therefore expanding the use of therapy devices in rehabilitation settings.
Advanced Device Costs and Therapist Shortages Restrain Market Expansion
High acquisition costs for advanced therapy devices can make investment difficult for smaller hospitals, physiotherapy clinics, and rehabilitation centers. Robotic systems, specialized rehabilitation devices, and advanced electrotherapy devices often require significant upfront spending. Higher capital requirements can delay equipment upgrades and limit adoption among budget-constrained providers.
Limited availability of trained therapists can restrict the effective use of specialized rehabilitation technology and physical therapy equipment. Certain devices require skilled professionals to select treatment settings, monitor patients, and adjust therapy based on recovery needs. Workforce shortages can therefore reduce utilization and limit expansion in underserved facilities.
Development of Wearable Neuromuscular Stimulation and Multi-Modal Therapy Systems Offer Growth Opportunities
Wearable neuromuscular stimulation devices can deliver controlled electrical stimulation during movement, exercise, or daily activities. Compact designs can support muscle activation and functional therapy outside conventional treatment rooms. This creates a base for the deployment of portable products that combine treatment flexibility with patient convenience.
Combination therapy devices can integrate modalities such as electrotherapy and therapeutic ultrasound within a single system. Multi-modal platforms can support different treatment needs without requiring separate equipment for each therapy. This creates opportunities for integrated therapeutic solution providers with broader clinical use.
Protocol Variations and Outcome Measurement Gaps Hinder Growth
Variation in therapist treatment protocols can lead to differences in treatment intensity, session duration, device settings, and application methods. Such variation can affect how therapy devices are used across clinics and may produce inconsistent patient results. This makes standardized treatment delivery more difficult.
Difficulty measuring patient recovery outcomes can make the value of some therapeutic solutions harder to demonstrate. Changes in pain, mobility, muscle function, and daily activity may vary between patients and require different assessment methods. Limited outcome comparability can make it harder for providers to judge device effectiveness.
The respiratory therapy devices segment accounted for a share of 12.63% in 2025, with the use of ventilators, CPAP systems, BiPAP machines, and other devices for breathing support. Their application across respiratory conditions supports continued demand in clinical and homecare settings.
The insulin pumps segment accounted for a share of 8.92% in 2025, driven by the ability to deliver insulin continuously and at programmed doses. This controlled delivery supports the use of insulin pumps in long-term diabetes management.
Request Customizationto receive a tailored report.
The pain management segment accounted for a share of 16.28% in 2025, as device-based treatment offers an option for patients requiring non-drug or complementary pain management approaches.
The sleep apnea segment is expected to grow at a CAGR of 8.68% during the forecast period, fueled by the adoption of CPAP, BiPAP, and other devices that help maintain airway function during sleep. Their ability to deliver positive airway pressure directly addresses the breathing interruptions associated with obstructive sleep apnea.
The hospitals & specialty clinics segment accounted for a share of 38.64% in 2025, supported by the availability of specialized equipment and trained professionals for device-based therapies. These settings accommodate patients requiring supervised and clinically intensive treatment.
The home healthcare settings segment is expected to grow at a CAGR of 8.24% during the forecast period, propelled by the use of portable and wearable therapy devices outside clinical facilities. Home-based devices allow patients to continue routine treatment while reducing the need for frequent facility visits.
Speak to an Analystto discuss market opportunities.
North America: Market Leadership Driven by Adoption of Neuromodulation Devices and Electrotherapy
The North America therapy devices market accounted for the largest regional share of 45.08% in 2025, supported by strong demand for respiratory therapy equipment, pain management technologies, and rehabilitation solutions.
The U.S. therapy devices market is supported by expanding use of respiratory therapy devices and neuromodulation systems. The U.S. FDA recognizes a dedicated international standard for high-flow respiratory therapy equipment. The U.S. military health authorities advanced clinical guidance for neuromodulation devices used in chronic pain therapy management.
The Canada therapy devices market benefits from the use of electrotherapy and infusion therapy equipment, particularly for home-based and chronic care applications. Canada’s medical expense guidance specifically recognizes TENS, electrical muscle stimulation, iontophoresis, electronic bone-healing devices, and infusion pumps as eligible medical devices when prescribed, supporting their established role in therapeutic care.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific: Fastest Growth Driven by Established Guidelines and Demand for Diabetes Management Devices
The Asia Pacific therapy devices market is expected to grow at a CAGR of 8.73% during the forecast period, supported by expanding rehabilitation technology, physiotherapy equipment, and advanced therapeutic equipment for chronic and mobility-related conditions.
The Japan therapy devices market is supported by the adoption of therapeutic ultrasound and rehabilitation equipment. Japan’s PMDA maintained dedicated review guidelines for ultrasound therapy devices used for pain relief and physiotherapy, supporting standardized development and clinical use of these devices.
The China therapy devices market benefits from the demand for insulin pumps and diabetes management devices. China’s State Council issued measures to strengthen regulation and innovation across medical devices, supporting development and wider availability of advanced therapeutic technologies.
The India therapy devices market is led by expanding wound care technologies and physiotherapy services. India’s Ministry of Health has launched competency-based curricula covering physiotherapy and related rehabilitation professions, while a government-backed program also advanced indigenous diabetic-foot wound therapy technology.
Europe: Market Development Fueled by Robust Sports Medicine Infrastructure and Adoption of Physiotherapy-led Pain Management
The Europe therapy devices market is expected to grow at a CAGR of 6.41% during the forecast period, supported by rising demand for sports medicine devices, electrical stimulation therapy, and compression-based treatment technologies.
The UK therapy devices market is supported by electrical stimulation therapy and physiotherapy-led pain management. NHS guidance continues to recognize TENS as a treatment option for pain associated with conditions, including sports injuries, supporting demand for electrical stimulation devices.
The Germany therapy devices market benefits from established sports medicine and compression treatment infrastructure. Germany’s statutory accident insurance system operates specialized outpatient treatment centers providing intensive therapy for complex musculoskeletal and sports-related injuries, supporting demand for advanced therapy equipment.
Latin America: Market Expansion Led by
The Latin America therapy devices market is expected to grow at a CAGR of 7.11% during the forecast period. Brazil’s therapy devices market is expected to benefit from the Novo PAC Saúde program, which plans 23 new Specialized Rehabilitation Centers (CERs) with investment of USD 38 million, expanding access to physical, intellectual, visual, and hearing rehabilitation services. Mexico’s therapy devices market is expected to benefit from the federal Program for Attention to Persons with Disabilities, which provides funding for rehabilitation equipment, including electrical stimulation, hydrotherapy, specialized rehabilitation equipment, wheelchairs, prostheses, and orthoses.
Middle East & Africa: Market Shaped by Locally Developed Rehabilitation Solutions
The Middle East & Africa therapy devices market is expected to grow at a CAGR of 6.58% during the forecast period. In the UAE, the government’s Olympic & Sports Science Centre uses pneumatic compression, radiofrequency, electromagnetic, shockwave, and therapeutic laser systems for injury management and recovery. In South Africa, the Department of Science, Technology, and Innovation launched locally developed assistive technologies to support people with disabilities, strengthening the country’s rehabilitation-device ecosystem.
The therapy devices market competitive landscape is diverse and moderately concentrated, with participation from global medical device manufacturers, cardiovascular and neuromodulation companies, rehabilitation technology providers, and pain management specialists. Key players such as Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, OMRON Healthcare, Inc., and DJO, LLC, are collectively estimated to account for approximately 25–30% of the global therapy devices market share.
Established participants compete primarily through device efficacy, clinical validation, technological innovation, physician relationships, and manufacturing capabilities. Emerging, niche, and regional companies in the therapy devices market ecosystem compete through minimally invasive devices, wearable and portable systems, customized treatment solutions, and cost-efficient products targeted at specific medical conditions and care settings.
June 2026: The FDA established Class II classification and special controls for external lower-extremity nerve stimulators for restless legs syndrome.
April 2026: The FDA classified digital therapeutics (DTx) devices for amblyopia as Class II devices.
March 2026: Philips received FDA 510(k) clearance for EchoNavigator R5.0 with DeviceGuide, an AI-powered solution that tracks and visualizes mitral-valve repair devices.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Asia Pacific Advanced Wound Dressing Market Size,Trends and Competitive Analysis 2034
North America Advanced Wound Dressing Market Size, Share & Trends | Industry Report, 2034
Europe Advanced Wound Dressing Market Size, Share and Forecast to 2034
Computed Tomography Market Size, Share, Growth, 2034
Biodegradable Stents Market Size, Share, Growth, Analysis, 2034
Hemoglobinopathies Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com